Skip to main content

Alopecia News (Page 2)

Related terms: Alopecia Areata, Balding, Baldness, Baldness, female pattern, Hair Loss, Hairloss, Hair Thinning, Loss of Hair

FDA Approves Leqselvi for Severe Alopecia

FRIDAY, Aug. 2, 2024 – The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata. Leqselvi (8 mg) is a twice-daily...

FDA Approves Leqselvi (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata

MUMBAI, India and PRINCETON, N.J., July 26, 2024 /PRNewswire/ – Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its...

FDA Approves Litfulo (ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata

NEW YORK--(BUSINESS WIRE) June 23, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Litfulo™ (ritlecitinib), a once-daily oral treatment, f...

FDA Approves Lilly and Incyte's Olumiant (baricitinib) as First and Only Systemic Medicine for Adults with Severe Alopecia Areata

INDIANAPOLIS, June 13, 2022 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has approved Olumiant...

FDA Medwatch Alert: Perfect Image Solutions Topical Hair Regrowth Products: Recall - Unapproved Drugs, Risk of Health Hazards

Men's Minoxidil 15% Azelaic 5% Hair regrowth topical, 60ml Men's Minoxidil 10% Azelaic 5% Hair regrowth topical, 60mL Men's Minoxidil 5% Azelaic 5% Hair regrowth topical, 60mL Women's Minoxidil 3%...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Dermatological Disorders

Related drug support groups

spironolactone, triamcinolone, Rogaine